NanoVibronix And VA Supplier CB Medical Announce Distribution Agreement For TheUroShield
Portfolio Pulse from Benzinga Newsdesk
NanoVibronix, Inc. has entered into a distribution agreement with CB Medical for the sale and distribution of its UroShield product, aimed at reducing catheter-associated urinary tract infections and discomfort.
May 14, 2024 | 12:50 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
The distribution agreement with CB Medical for UroShield could potentially increase NanoVibronix's market penetration and sales, positively impacting its financial performance.
Distribution agreements typically expand market access and sales potential for medical device companies. Given UroShield's unique value proposition in reducing CAUTI and discomfort, this partnership could significantly enhance NanoVibronix's revenue and market presence in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100